H.R. 45House114th Congress (2015-2017)In Committee

Triple-Negative Breast Cancer Research and Education Act of 2015

Introduced January 6, 2015

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
HouseCommittee Latest Action

Referred to the Subcommittee on Health.

January 9, 2015

View full timeline
HouseIntro Referral

Introduced in House

January 6, 2015

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

January 6, 2015

HouseCommittee

Referred to the Subcommittee on Health.

January 9, 2015

Floor Debate

15 members

What members said about H.R. 45 on the floor

5 Republicans10 Democrats
James P. McGovern
Rep. James P. McGovernD-MA-2 · Feb 3, 2015

Mr. Speaker, I want to thank the gentleman from Texas for the customary 30 minutes. I yield myself such time as I may consume. Mr. Speaker, first of all, I rise in very strong opposition to this…

Michael C. Burgess
Rep. Michael C. BurgessR-TX-26 · Feb 3, 2015

Mr. Speaker, by direction of the Committee on Rules, I call up House Resolution 70 and ask for its immediate consideration. Mr. Speaker, for the purpose of debate only, I yield the customary 30…

Nancy Pelosi
Rep. Nancy PelosiD-CA-12 · Feb 3, 2015

Mr. Speaker, I thank the gentleman for yielding and for his leadership on this important issue, as important as the health of the American people. I salute Congresswoman Brownley for her alternative…

Pete Sessions
Rep. Pete SessionsR-TX-32 · Feb 3, 2015

Mr. Speaker, I am delighted to rise on the floor today really for two reasons, perhaps three. First of all, to support and defend the Committee on Rules last night where we overwhelmingly are in…

Steve King
Rep. Steve KingR-IA-4 · Feb 3, 2015

Mr. Speaker, I thank the gentleman from Texas for yielding and for leading around this Nation on this issue. So far away from Texas as even Iowa, the gentleman from Texas has fought for the full 100…

Show 8 more
Sheila Jackson Lee
Rep. Sheila Jackson LeeD-TX-18 · Feb 3, 2015

Mr. Speaker, I thank the gentleman from Massachusetts for being astute in reminding us of the vast bipartisan support for the important Affordable Care Act. If I might add, the past Presidential…

Doris O. Matsui
Rep. Doris O. MatsuiD-CA-6 · Feb 3, 2015

I thank the gentleman for yielding. Mr. Speaker, I rise today in strong opposition to the rule and the underlying legislation. Here we go again. This bill marks yet another attempt by the Republican…

Brendan F. Boyle
Rep. Brendan F. BoyleD-PA-13 · Feb 3, 2015

Mr. Speaker, I thank the gentleman from Massachusetts. Mr. Speaker, I also want to thank the Republican majority. As a new Member, I haven't had the opportunity to speak on this issue on the House…

Rosa L. DeLauro
Rep. Rosa L. DeLauroD-CT-3 · Feb 3, 2015

Mr. Speaker, yesterday was Groundhog Day. How appropriate that the Republican majority chose today for their 56th attempt to repeal or to undermine the Affordable Care Act. These futile, ideological…

Julia Brownley
Rep. Julia BrownleyD-CA-26 · Feb 3, 2015

Mr. Speaker, instead of wasting time on bills that would strip health care away from millions of Americans, we should be focusing on legislation like my bill, the American Manufacturing Jobs for…

Debbie Dingell
Rep. Debbie DingellD-MI-12 · Feb 3, 2015

Mr. Speaker, I thank the gentleman for yielding. I rise in opposition to the rule and the underlying bill. I may be new to this Chamber, but it sure seems like Groundhog Day around here to me. This…

Ed Perlmutter
Rep. Ed PerlmutterD-CO-7 · Feb 3, 2015

Thank you, Mr. McGovern, for giving me a chance to tell a little personal story about the success of the Affordable Care Act and its impact on the Perlmutter family. On election day, my wife, a…

John A. Yarmuth
Rep. John A. YarmuthD-KY-3 · Feb 3, 2015

I thank my friend from Massachusetts. Mr. Speaker, today, we will take our 56th vote to repeal or undermine the Affordable Care Act. In my home State of Kentucky--a nationwide success story of this…

Show 2 more
Dan Benishek
Rep. Dan BenishekR-MI-1 · Feb 3, 2015

Mr. Speaker, I rise today in strong support of the rule and the underlying bill. I have been a doctor in northern Michigan for 30 years, and I have always put the needs of my patients first. I…

Gus M. Bilirakis
Rep. Gus M. BilirakisR-FL-12 · Feb 3, 2015

Thank you, Dr. Burgess. You are doing an outstanding job with this course and health care in general. I appreciate it so very much. I know my constituents do. Mr. Speaker, I rise today in support of…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in HouseIssued January 6, 2015

I

114th CONGRESS

1st Session

H. R. 45

IN THE HOUSE OF REPRESENTATIVES

January 6, 2015

Ms. Jackson Lee introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To provide for research and education with respect to triple-negative breast cancer, and for other purposes.

1.

Short title

This Act may be cited as the Triple-Negative Breast Cancer Research and Education Act of 2015.

2.

Findings

Congress finds as follows:

(1)

Breast cancer accounts for 1 in 4 cancer diagnoses among women in this country.

(2)

The survival rate for breast cancer has increased to 90 percent for White women and 78 percent for African-American women.

(3)

African-American women are more likely to be diagnosed with larger tumors and more advanced stages of breast cancer despite a lower incidence rate.

(4)

Early detection for breast cancer increases survival rates for breast cancer, as evidenced by a 5-year relative survival rate of 98 percent for breast cancers that are discovered before the cancer spreads beyond the breast, compared to 23 percent for stage IV breast cancers.

(5)

Triple-negative breast cancer is a term used to describe breast cancers whose cells do not have estrogen receptors and progesterone receptors, and do not have an excess of the HER2 protein on their sources.

(6)

It is estimated that between 10 and 20 percent of female breast cancer patients are diagnosed with triple-negative breast cancer, and studies indicate the prevalence of triple-negative breast cancer is much higher.

(7)

Triple-negative breast cancer most commonly affects African-American women, followed by Hispanic women.

(8)

Triple-negative breast cancer is a very aggressive form of cancer which affects women under the age of 50 across all racial and socioeconomic backgrounds.

(9)

African-American women are 3 times more likely to develop triple-negative breast cancer than White women.

(10)

Triple-negative breast cancer tends to grow and spread more quickly than most other types of breast cancer.

(11)

Like other forms of breast cancer, triple-negative breast cancer is treated with surgery, radiation therapy, or chemotherapy.

(12)

Early-stage detection of triple-negative breast cancer is the key to survival because the tumor cells lack certain receptors, and neither hormone therapy nor drugs that target these receptors are effective against these cancers; therefore, early detection and education is vital.

(13)

Current research and available data do not provide adequate information on—

(A)

the rates of prevalence and incidence of triple-negative breast cancer in African-American, Hispanic, and other minority women;

(B)

the costs associated with treating triple-negative breast cancer; and

(C)

the methods by which triple-negative breast cancer may be prevented or cured in these women.

3.

Research with respect to triple-negative breast cancer

(a)

Research

The Director of the National Institutes of Health (in this section referred to as the Director of NIH) shall expand, intensify, and coordinate programs for the conduct and support of research with respect to triple-negative breast cancer.

(b)

Administration

The Director of NIH shall carry out this section through the appropriate institutes, offices, and centers of the National Institutes of Health, including the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Environmental Health Sciences, the Office of Research on Women’s Health, and the National Institute on Minority Health and Health Disparities.

(c)

Coordination of activities

The Director of the Office of Research on Women’s Health shall coordinate activities under this section among the institutes, offices, and centers of the National Institutes of Health.

(d)

Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated $500,000 for each of the fiscal years 2016 through 2018.

4.

Education and dissemination of information with respect to triple-negative breast cancer

(a)

Triple-Negative breast cancer public education program

The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, shall develop and disseminate to the public information regarding triple-negative breast cancer, including information on—

(1)

the incidence and prevalence of triple-negative breast cancer among women;

(2)

the elevated risk for minority women to develop triple-negative breast cancer; and

(3)

the availability, as medically appropriate, of a range of treatment options for symptomatic triple-negative breast cancer.

(b)

Dissemination of information

The Secretary may disseminate information under subsection (a) directly or through arrangements with nonprofit organizations, consumer groups, institutions of higher education, Federal, State, or local agencies, or the media.

(c)

Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2016 through 2018.

5.

Information to health care providers with respect to triple-negative breast cancer

(a)

Dissemination of information

The Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, shall develop and disseminate to health care providers information on triple-negative breast cancer for the purpose of ensuring that health care providers remain informed about current information on triple-negative breast cancer. Such information shall include the elevated risk for minority women to develop triple-negative breast cancer and the range of available options for the treatment of symptomatic triple-negative breast cancer.

(b)

Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated such sums as may be necessary for each of the fiscal years 2016 through 2020.

6.

Definition

In this Act, the term minority women means women who are members of a racial and ethnic minority group, as defined in section 1707(g) of the Public Health Service Act (42 U.S.C. 300u–6(g)).